melanin concentrating hormone antagonists (Neurocrine)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemelanin concentrating hormone antagonists (Neurocrine)
Drug Alias NameMCH antagonist (Neurocrine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanin-concentrating hormone receptor 1 inhibitors
TargetsMelanin-concentrating hormone receptor 1
Therapy Area/IndicationsAnxiety DisordersDepressionObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersDepressionObesity

Other Information

ATC CodeN/A
Related LinksN/A